Latest filings (excl ownership)
15-12G
Securities registration termination
14 Mar 23
EFFECT
Notice of effectiveness
9 Mar 23
EFFECT
Notice of effectiveness
9 Mar 23
EFFECT
Notice of effectiveness
9 Mar 23
EFFECT
Notice of effectiveness
9 Mar 23
EFFECT
Notice of effectiveness
9 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
POS AM
Prospectus update (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
POS AM
Prospectus update (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
POS AM
Prospectus update (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
POS AM
Prospectus update (post-effective amendment)
2 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 23
POS AM
Prospectus update (post-effective amendment)
2 Mar 23
25-NSE
Exchange delisting
2 Mar 23
8-K
Completion of Acquisition or Disposition of Assets
2 Mar 23
SC 14D9/A
Tender offer solicitation (amended)
2 Mar 23
SC TO-T/A
Third party tender offer statement (amended)
2 Mar 23
SC 14D9/A
Tender offer solicitation (amended)
22 Feb 23
SC TO-T/A
Third party tender offer statement (amended)
22 Feb 23
8-K
Other Events
14 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
30 Jan 23
SC 14D9
Tender offer solicitation
23 Jan 23
SC TO-T
Third party tender offer statement
23 Jan 23
SC14D9C
Written communication relating to third party tender offer
19 Jan 23
SC TO-C
Information about tender offer
10 Jan 23
SC TO-C
Information about tender offer
9 Jan 23
SC14D9C
Written communication relating to third party tender offer
9 Jan 23
8-K
Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
9 Jan 23
8-K
Departure of Directors or Certain Officers
6 Dec 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
Albireo Reports Q3 2022 Financial Results and Business Update
8 Nov 22
8-K
Albireo Reports Positive Topline Data from Phase 3 Trial of Bylvay® (odevixibat) in Alagille Syndrome
11 Oct 22
Latest ownership filings
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G/A
FEDERATED HERMES, INC.
10 Apr 23
SC 13G/A
BlackRock Inc.
8 Mar 23
4
David Chiswell
3 Mar 23
4
Susan Alesina
2 Mar 23
4
Stephanie Okey
2 Mar 23
4
Simon N.R. Harford
2 Mar 23
4
Ronald Harold Wilfred Cooper
2 Mar 23
4
PAUL STRECK
2 Mar 23
4
Pamela Stephenson
2 Mar 23
4
Michelle Graham
2 Mar 23
4
Michael Gutch
2 Mar 23
4
Martha J. Carter
2 Mar 23
4
Jason Duncan
2 Mar 23
4
Jan Mattsson
2 Mar 23
4
Habib J Dable
2 Mar 23
4
DAVEY SCOON
2 Mar 23
4
Craig C. Hopkinson
2 Mar 23
SC 13G
ICS OPPORTUNITIES, LTD.
2 Mar 23
SC 13G
Beryl Capital Management LLC
27 Feb 23
SC 13G
CARLSON CAPITAL L P
24 Feb 23
SC 13G/A
TANG CAPITAL PARTNERS LP
14 Feb 23
SC 13G/A
PERCEPTIVE ADVISORS LLC
14 Feb 23
SC 13G/A
Deep Track Capital, LP
14 Feb 23
SC 13G/A
STATE STREET CORP
1 Feb 23
SC 13G/A
FEDERATED HERMES, INC.
1 Feb 23
SC 13G/A
BlackRock Inc.
1 Feb 23
4/A
Ronald Harold Wilfred Cooper
27 Jan 23
4/A
Jan Mattsson
27 Jan 23
4/A
Martha J. Carter
27 Jan 23
4/A
Jason Duncan
27 Jan 23
4/A
Michelle Graham
27 Jan 23
4/A
Simon N.R. Harford
27 Jan 23
4/A
Pamela Stephenson
27 Jan 23
4/A
PAUL STRECK
27 Jan 23
4
Ronald Harold Wilfred Cooper
25 Jan 23
4
Jan Mattsson
25 Jan 23
4
Martha J. Carter
25 Jan 23
4
Jason Duncan
25 Jan 23
4
Michelle Graham
25 Jan 23